66 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34551150 | Melatonin enhances cisplatin-induced cell death through inhibition of DERL1 in mesenchymal-like CD44high OSCC cells. | 2022 Mar | 4 |
2 | 35398618 | Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration. | 2022 May | 1 |
3 | 32700607 | Phytol Down-Regulates Expression of Some Cancer Stem Cell Markers and Decreases Side Population Proportion in Human Embryonic Carcinoma NCCIT Cells. | 2021 | 1 |
4 | 33610575 | Vincamine protects against cisplatin induced nephrotoxicity via activation of Nrf2/HO-1 and hindering TLR4/ IFN-γ/CD44 cells inflammatory cascade. | 2021 May 1 | 1 |
5 | 33919109 | Regulation of Cellular and Cancer Stem Cell-Related Putative Gene Expression of Parental and CD44+CD24- Sorted MDA-MB-231 Cells by Cisplatin. | 2021 Apr 21 | 1 |
6 | 34076552 | Identification of Chemo and Radio-Resistant Sub-Population of Stem Cells in Human Cervical Cancer HeLa Cells. | 2021 Sep | 1 |
7 | 34123574 | Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness. | 2021 Jun 1 | 1 |
8 | 34400945 | Effect of Menadione and Combination of Gemcitabine and Cisplatin on Cancer Stem Cells in Human Non-small Cell Lung Cancer (NSCLC) Cell Line A549. | 2021 Winter | 2 |
9 | 34680456 | NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44. | 2021 Sep 28 | 1 |
10 | 31953176 | Inhibition of CD44 sensitizes cisplatin-resistance and affects Wnt/β-catenin signaling in HNSCC cells. | 2020 Apr 15 | 4 |
11 | 32151664 | Construction of redox-responsive tumor targeted cisplatin nano-delivery system for effective cancer chemotherapy. | 2020 Apr 30 | 1 |
12 | 32244823 | CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells. | 2020 Apr 1 | 1 |
13 | 32252293 | Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells. | 2020 Apr 2 | 2 |
14 | 32527702 | MiR-486-5p enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by induction of apoptosis and down-regulation of metastatic genes. | 2020 Sep | 1 |
15 | 30077625 | Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance. | 2019 May | 2 |
16 | 30485589 | Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells. | 2019 Feb | 3 |
17 | 31781681 | Mutated p53 Promotes the Symmetric Self-Renewal of Cisplatin-Resistant Lung Cancer Stem-Like Cells and Inhibits the Recruitment of Macrophages. | 2019 | 2 |
18 | 29171106 | Autophagy regulates cisplatin-induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma. | 2018 Feb | 3 |
19 | 29385995 | Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer. | 2018 Jan 31 | 2 |
20 | 29515788 | CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells. | 2018 Feb 9 | 3 |
21 | 30182373 | EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells. | 2018 Dec | 1 |
22 | 30448176 | CD44v-dependent upregulation of xCT is involved in the acquisition of cisplatin-resistance in human lung cancer A549 cells. | 2018 Dec 9 | 1 |
23 | 26910918 | Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy. | 2017 Jan 31 | 1 |
24 | 27244887 | Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer. | 2017 May 9 | 1 |
25 | 27999837 | Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels. | 2017 Jan 5 | 1 |
26 | 28107698 | The natural flavonoid apigenin sensitizes human CD44+ prostate cancer stem cells to cisplatin therapy. | 2017 Apr | 2 |
27 | 28466360 | Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407). | 2017 Nov | 1 |
28 | 28903181 | Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor. | 2017 Nov | 1 |
29 | 28961534 | Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity. | 2017 Dec | 1 |
30 | 29029509 | Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations. | 2017 Sep 12 | 1 |
31 | 29110853 | CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment. | 2017 Nov | 1 |
32 | 27040816 | Eradication of CD44-variant positive population in head and neck tumors through controlled intracellular navigation of cisplatin-loaded nanomedicines. | 2016 May 28 | 1 |
33 | 26117979 | Innovative therapy of ovarian cancer based on overexpression of CD44 receptor. | 2015 May | 1 |
34 | 26338199 | Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro. | 2015 Sep 4 | 1 |
35 | 26349992 | Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells. | 2015 Aug | 2 |
36 | 26448751 | Carboxymethyl Hyaluronan-Stabilized Nanoparticles for Anticancer Drug Delivery. | 2015 | 1 |
37 | 26609473 | LIN28B suppresses microRNA let-7b expression to promote CD44+/LIN28B+ human pancreatic cancer stem cell proliferation and invasion. | 2015 | 1 |
38 | 24423412 | Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. | 2014 Jan 15 | 2 |
39 | 24606473 | Reversal of resistance towards cisplatin by curcumin in cervical cancer cells. | 2014 | 3 |
40 | 24612587 | Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma. | 2014 Mar 11 | 1 |
41 | 24681046 | A simple and general method for preparing antibody-PEG-PLGA sub-micron particles using electrospray technique: an in vitro study of targeted delivery of cisplatin to ovarian cancer cells. | 2014 May 1 | 3 |
42 | 24684961 | Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture. | 2014 Aug | 1 |
43 | 24884875 | Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity. | 2014 Apr 30 | 3 |
44 | 24947926 | CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance. | 2014 Aug 1 | 1 |
45 | 25299431 | Highly sensitive and selective anticancer effect by conjugated HA-cisplatin in non-small cell lung cancer overexpressed with CD44. | 2014 Dec | 4 |
46 | 22473523 | Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression. | 2013 Apr | 1 |
47 | 22770891 | CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits. | 2013 Jan | 1 |
48 | 23265944 | CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression. | 2013 Apr | 1 |
49 | 23368632 | Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures. | 2013 Jan 31 | 1 |
50 | 23715169 | A tissue-engineered gastric cancer model for mechanistic study of anti-tumor drugs. | 2013 Aug | 1 |